Disclosure 0001628280-26-061581-17

SEC FORM 4

$116,835.68

MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Sale of 218 shares at $535.9435 per share.

Reporting Person Sibold William John · Officer Title President and CEO · Transaction Code S

Traded Sep 11, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001628280-26-061581 · filed 2026-09-11 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "MADRIGAL PHARMACEUTICALS, INC. (MDGL)." Disclosed 2026-09-11. https://desqlong.com/cards/0001628280-26-061581-17 (retrieved 2026-09-26).